URS
VRTX icon

Utah Retirement Systems’s Vertex Pharmaceuticals VRTX Stock Holding History

Utah Retirement Systems’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Sell
41,265
-1,225
-3% -$571K 0.19% 94
2025
Q4 		$19.3M Sell
42,490
-9
-0% -$3.88K 0.18% 98
2025
Q3 		$16.6M Sell
42,499
-34
-0.1% -$14.2K 0.16% 112
2025
Q2 		$18.9M Sell
42,533
-270
-0.6% -$124K 0.2% 96
2025
Q1 		$20.8M Sell
42,803
-100
-0.2% -$46.6K 0.24% 84
2024
Q4 		$17.3M Buy
42,903
+100
+0.2% +$46.4K 0.19% 96
2024
Q3 		$19.9M Buy
42,803
+157
+0.4% +$75.4K 0.22% 81
2024
Q2 		$20M Sell
42,646
-2,034
-5% -$883K 0.24% 82
2024
Q1 		$18.7M Sell
44,680
-35
-0.1% -$14.8K 0.22% 90
2023
Q4 		$18.2M Buy
44,715
+354
+0.8% +$131K 0.23% 87
2023
Q3 		$15.4M Buy
44,361
+100
+0.2% +$35K 0.22% 90
2023
Q2 		$15.6M Sell
44,261
-1,258
-3% -$424K 0.22% 92
2023
Q1 		$14.3M Buy
45,519
+140
+0.3% +$42K 0.21% 100
2022
Q4 		$13.1M Sell
45,379
-469
-1% -$143K 0.21% 107
2022
Q3 		$13.3M Buy
45,848
+251
+0.6% +$72.2K 0.22% 91
2022
Q2 		$12.8M Buy
45,597
+158
+0.3% +$42.3K 0.21% 99
2022
Q1 		$11.9M Sell
45,439
-800
-2% -$190K 0.16% 122
2021
Q4 		$10.2M Sell
46,239
-600
-1% -$117K 0.13% 151
2021
Q3 		$8.5M Sell
46,839
-2,600
-5% -$508K 0.11% 169
2021
Q2 		$9.97M Sell
49,439
-400
-0.8% -$83.7K 0.13% 155
2021
Q1 		$10.7M Sell
49,839
-2,200
-4% -$483K 0.15% 136
2020
Q4 		$12.3M Buy
52,039
+2,200
+4% +$505K 0.17% 122
2020
Q3 		$13.6M Buy
49,839
+300
+0.6% +$82.8K 0.23% 89
2020
Q2 		$14.4M Buy
49,539
+500
+1% +$136K 0.26% 77
2020
Q1 		$11.7M Buy
49,039
+100
+0.2% +$22.9K 0.25% 82
2019
Q4 		$10.7M Buy
48,939
+200
+0.4% +$40.5K 0.19% 114
2019
Q3 		$8.26M Buy
48,739
+300
+0.6% +$53.1K 0.16% 139
2019
Q2 		$8.88M Buy
48,439
+244
+0.5% +$42.7K 0.17% 122
2019
Q1 		$8.87M Buy
48,195
+668
+1% +$123K 0.18% 117
2018
Q4 		$7.88M Buy
47,527
+100
+0.2% +$17.3K 0.18% 120
2018
Q3 		$9.14M Buy
47,427
+200
+0.4% +$35.6K 0.18% 116
2018
Q2 		$8.03M Buy
47,227
+300
+0.6% +$46.5K 0.17% 128
2018
Q1 		$7.65M Buy
46,927
+100
+0.2% +$16.3K 0.16% 131
2017
Q4 		$7.02M Buy
46,827
+600
+1% +$88.8K 0.15% 146
2017
Q3 		$7.03M Buy
46,227
+700
+2% +$105K 0.16% 139
2017
Q2 		$5.87M Buy
45,527
+500
+1% +$60.2K 0.14% 164
2017
Q1 		$4.92M Hold
45,027
– – 0.12% 187
2016
Q4 		$3.32M Sell
45,027
-100
-0.2% -$8.14K 0.08% 257
2016
Q3 		$3.94M Hold
45,127
– – 0.1% 221
2016
Q2 		$3.88M Buy
45,127
+1,300
+3% +$112K 0.1% 218
2016
Q1 		$3.48M Hold
43,827
– – 0.09% 226
2015
Q4 		$5.51M Buy
43,827
+100
+0.2% +$12.1K 0.15% 142
2015
Q3 		$4.55M Buy
43,727
+300
+0.7% +$38.5K 0.13% 165
2015
Q2 		$5.36M Buy
43,427
+1,200
+3% +$151K 0.14% 151
2015
Q1 		$4.98M Buy
42,227
+1,300
+3% +$156K 0.13% 171
2014
Q4 		$4.86M Hold
40,927
– – 0.13% 165
2014
Q3 		$4.6M Hold
40,927
– – 0.13% 165
2014
Q2 		$3.88M Sell
40,927
-900
-2% -$63.1K 0.11% 197
2014
Q1 		$2.96M Buy
41,827
+300
+0.7% +$23.8K 0.09% 246
2013
Q4 		$3.08M Hold
41,527
– – 0.09% 222
2013
Q3 		$3.15M Buy
41,527
+1,700
+4% +$135K 0.1% 211
2013
Q2 		$3.18M Buy
+39,827
New +$2.93M 0.11% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Utah Retirement Systems's VRTX Position: Q1 2026 in Review

Utah Retirement Systems reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q1 2026, selling an estimated $571K and leaving 41,265 shares worth $18.4M. The position accounts for 0.19% of the portfolio, ranked #94.

Utah Retirement Systems first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Utah Retirement Systems held 41,265 shares of Vertex Pharmaceuticals worth $18.4M as of Q1 2026.
  • Utah Retirement Systems sold 1,225 Vertex Pharmaceuticals shares in Q1 2026, an estimated $571K.
  • Vertex Pharmaceuticals made up 0.19% of Utah Retirement Systems's portfolio in Q1 2026, its #94 holding.
  • Utah Retirement Systems first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Utah Retirement Systems's Vertex Pharmaceuticals position peaked at $20.8M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.